CARE Ratings Ltd released its financial results for the fourth quarter of FY25 on Tuesday, May 12, 2025.
In CARE Ratings Q4 results, the company posted a consolidated net profit of ₹43.4 crore. This marks a robust rise year-on-year (YoY) of 76.4% from ₹24.6 crore reported in the same quarter of the previous fiscal year.
Following this result, the shares opened 5.77% higher at ₹1,422 (the previous close was ₹1,344.4).
For the final quarter of FY25, CARE Ratings Ltd.’s revenue from operations reached ₹109.7 crore. It is around 21.8% up from ₹90.1 crore in the corresponding quarter last year.
Furthermore, CARE Ratings Q4 results revealed that the total revenue increased to ₹124.8 crore in Q4 FY25, an improvement from ₹100.4 crore reported in the same period the previous year.
CARE Ratings Ltd. Q4 Results Highlights
In this table, you will get an overview of CARE Ratings latest quarterly results:
| Q4 FY 2024-25 | Q3 FY 2024-25 | Q4 FY 2023-24 | YoY Growth (%) | QoQ Growth (%) | |
| Total Income (₹ in crore) | ₹124.8 | ₹108.2 | ₹100.4 | 24.3% | 15.3% |
| Net profit (₹ in crore) | ₹43.4 | ₹28.4 | ₹24.6 | 76.4% | 52.8% |
| EPS (Diluted) | ₹14.2 | ₹9.2 | ₹8 | 77.5% | 54.3% |
CARE Ratings Ltd’s Financial Results Comparison with the Previous Year
Here is a table of annual data comparison of CARE Ratings Q4 2025 results:
| FY 2024-25 | FY 2023-24 | |
| Total Income (in crore) | ₹453 | ₹378.4 |
| Net profit (in crore) | ₹140 | ₹102.6 |
| EPS | ₹45.7 | ₹33.7 |
Updates Shared by CARE Ratings in the Latest Financial Results
During the announcements of CARE Ratings Q4 results, the company’s management provided key notes on the quarterly results:
Dividend Announced
The Board of Directors has recommended a final dividend of ₹11 per share. Earlier, the company had paid an interim dividend of ₹7 per share in Q2 FY25. Total dividend for FY25: ₹18 per share.
Employee Stock Option Scheme (ESOS) 2020 Update
The Company has granted a total of 8,11,500 stock options under the ESOS 2020 to eligible employees on various dates, including previous periods.
These grants have been duly approved by the shareholders and the Nomination & Remuneration Committee.
In line with Ind AS 102 – Share-Based Payment, the total cost is being recognised over the vesting period.
Consolidated Financial Highlights
In CARE Ratings latest results, these are some of the key financial highlights:
- Revenue From Operations -> ₹109.7 crore (YoY 22%)
- EBITDA & EBITDA Margin (%) -> ₹47.4 crore (YoY 63%), EBITDA Margin % at 43%
- PAT & PAT Margin% -> ₹43.4 crore (YoY 77%), PAT Margin% at 35%
FY25 Segmental Breakup
Here is the segment-wise business breakup as per Q4 CARE Ratings results 2025:
- Ratings Business -> ₹360.1 crore (YoY 21%)
- Non-Ratings Business -> ₹42.2 crore (YoY 27%)
Fundraising Activity in the Economy
According to the Q4 CARE Ratings results, corporate bond issuances recorded a 6% year-on-year increase in FY25, while commercial paper issuances grew at a faster pace of 14.5% during the same period.
Bank Credit Offtake
According to CARE Ratings results, these are the highlights of Bank Credit Offtake:
- Overall credit growth to large industries and services moderated to 10.1%, down from 16.7% in March 2024.
- Credit to the services sector slowed due to a higher risk weightage for NBFCs.
- Restoration of previous risk weights on bank exposure to NBFCs is expected to boost credit growth going forward.
- Credit growth to large industries (which account for ~70% of total industrial credit) was at 6.2%, slightly lower than 6.4% in the previous year.
Happy with our detailed article on CARE Ratings Q4 results? Do follow Torus Digital and get regular updates regarding quarterly results, share market updates and geopolitical news.
